Endo Pharmaceuticals (NASDAQ:ENDP) reported Q3 EPS of $0.86, topping consensus estimates of $0.84. Revenues in the quarter jumped 23% to $444 million, inline with consensus estimates. Endo also reiterated its 2010 revenue guidance of between $1.63 billion and $1.68 billion dollars and full-year adjusted diluted earnings per share to be between $3.30 to $3.35 per [...]
Alberto-Culver (NYSE:ACV) reported fiscal Q4 EPS of $0.46, topping consensus estimates of $0.39. Revenues in the quarter rose 46% to $432 million, which was slightly higher than consensus estimates of $430 million. The company’s gross profit margin was 52.1% in the fourth quarter. On September 28, 2010, Alberto-Culver (NYSE:ACV) was downgraded to Market Perform from [...]
ETF Trading Pre Market Trends Trading Analysis Pre-Market Commentary. Pre Market Stock Market Trading Videos SMF MMTs Entries on Wall St Opening Bell. Pre Market Stock Market Trading Videos SMF MMTs Entries on Wall St Opening Bell. Pre-Market Trading | Premarket Stock Quotes. Pre-Market Most Active Stocks – NASDAQ Premarket. Day Trading – After Hours [...]
„Allergan (NYSE:AGN) reported Q3 EPS of $0.78, inline with consensus estimates. Revenues in the quarter jumped 5.7% to $1.2 billion, inline with consensus estimates. On October 19, 2010, Allergan (NYSE:AGN) was downgraded to Neutral from Buy at SunTrust. The stock is trading at $72.41 which is 0.95% higher than the downgrade price of $71.73.”…
Mixed Bag of Economic News today. We have the Personal Income, Personal Spending and Core PCE all down; but the ISM and Construction Spending both Up. The Stock Market is Up a bit today. The Bond Market started Up, but now is Trading at the Lower Range. It will probably hold this level until after [...]